What's new

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised

Mar 28, 2025 - 16:32
 0
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
Read More

Tags:

Previous Article

Another big payday for O'Day as Gilead boosts his compensation 5% to $23.7M

Next Article

Thames Water’s finance chief to stand down

Related Posts

Minutes of the CAT meeting 4-6 December 2024

Mar 24, 2025  0

Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Product Management Service (PMS) questions and aswers clinic - June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2025, 11:00 (CEST) to 17 June 2025, 12:00 (CEST)

Product Management Service (PMS) questions and aswers c...

Mar 7, 2025  0